PINI, ALESSANDRO
 Distribuzione geografica
Continente #
EU - Europa 6.335
NA - Nord America 5.987
AS - Asia 1.105
SA - Sud America 19
AF - Africa 17
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 11
Totale 13.488
Nazione #
US - Stati Uniti d'America 5.965
GB - Regno Unito 1.848
IT - Italia 1.042
IE - Irlanda 969
CN - Cina 689
SE - Svezia 597
UA - Ucraina 518
RU - Federazione Russa 400
DE - Germania 347
FR - Francia 261
SG - Singapore 185
FI - Finlandia 135
VN - Vietnam 88
ES - Italia 68
BE - Belgio 44
PL - Polonia 24
IR - Iran 22
TR - Turchia 22
CZ - Repubblica Ceca 21
CA - Canada 19
IN - India 19
NL - Olanda 17
HK - Hong Kong 15
AU - Australia 12
CI - Costa d'Avorio 11
EU - Europa 11
PK - Pakistan 10
AT - Austria 9
BR - Brasile 8
JP - Giappone 8
RO - Romania 8
IL - Israele 6
PH - Filippine 6
DK - Danimarca 5
PE - Perù 5
BD - Bangladesh 4
EG - Egitto 4
JO - Giordania 4
TW - Taiwan 4
AZ - Azerbaigian 3
CL - Cile 3
EE - Estonia 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
LT - Lituania 3
MX - Messico 3
RS - Serbia 3
EC - Ecuador 2
GR - Grecia 2
KG - Kirghizistan 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CH - Svizzera 1
GE - Georgia 1
HU - Ungheria 1
IQ - Iraq 1
KE - Kenya 1
KR - Corea 1
LK - Sri Lanka 1
MA - Marocco 1
MT - Malta 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 13.488
Città #
Southend 1.750
Dublin 958
Fairfield 778
Chandler 554
Ashburn 478
Siena 471
Jacksonville 424
Woodbridge 400
Ann Arbor 349
Seattle 323
Wilmington 321
Houston 297
Menlo Park 260
Cambridge 246
Beijing 171
Princeton 171
Singapore 137
Nanjing 133
Dong Ket 87
Boardman 83
New York 80
San Mateo 67
Málaga 60
Helsinki 57
Nanchang 55
Shanghai 53
San Diego 50
Florence 47
Dearborn 42
Fremont 42
Rome 41
Shenyang 39
Brussels 34
Hebei 34
Moscow 31
Redwood City 29
Kunming 23
Washington 22
Bagno a Ripoli 21
Milan 21
Tianjin 21
Brno 19
Changsha 18
Los Angeles 18
Jiaxing 17
London 16
Ningbo 16
Izmir 15
Gdansk 14
Chicago 13
Düsseldorf 13
Toronto 13
Dallas 12
Kansas City 12
Phoenix 12
Zhengzhou 12
Abidjan 11
Jinan 11
Munich 11
Arezzo 10
Hangzhou 10
Lancaster 10
San Francisco 10
Norwalk 9
University Park 9
Venezia 9
Vienna 9
Zanjan 9
Guangzhou 8
Tappahannock 8
Auburn Hills 7
Colle Di Val D'elsa 7
Hong Kong 7
Santa Clara 7
Atlanta 6
Lanzhou 6
Nürnberg 6
Overijse 6
Stockholm 6
Taizhou 6
Catania 5
Columbus 5
Fuzhou 5
Kilburn 5
Lappeenranta 5
Leawood 5
Lima 5
Naples 5
Radomsko 5
Waukegan 5
Amman 4
Amsterdam 4
Barcelona 4
Beitou 4
Changchun 4
Como 4
Cosenza 4
Grosseto 4
Hefei 4
Melbourne 4
Totale 9.768
Nome #
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging 267
The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells 258
Insights into the role of sulfated glycans in cancer cell adhesion and migration through use of branched peptide probe 253
Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumoniae and P. aeruginosa 253
The proteome speciation of an immortalized cystic fibrosis cell line: New perspectives on the pathophysiology of the disease 231
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions. 223
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug 214
In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate 207
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens 206
Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer 203
Tumor imaging with tetrabranched neurotensin 201
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. 197
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity 197
Supramolecular aggregates as drug carriers on cell expressing receptors for branched Neurotensin 194
Heparan sulfate proteoglycans can promote opposite effects on adhesion and directional migration of different cancer cells 193
A new NT4 peptide-based drug delivery system for cancer treatment 176
Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate 174
Branched peptides for tumor diagnosis and therapy 172
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. 171
Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens 171
Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase 169
Branched Neurotensin For Tumor Targeting 168
D-Amino acids incorporation in the frog skin-derived peptide esculentin-1a(1-21)NH2 is beneficial for its multiple functions 167
Antimicrobial activity of levofloxacin - M33 peptide conjugation or combination 165
An antimicrobial molecule mitigates signs of sepsis in vivo and eradicates infections from lung tissue 165
Branched peptides as bioactive molecules for drug design 164
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo 163
A novel phage-library-selected peptide inhibits human TNF-α binding to its receptors 162
Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections 162
Synthetic peptides in the form of dendrimers become resistant to protease activity 158
Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept 156
Esculentin-1a-derived peptides promote clearance of pseudomonas aeruginosa internalized in bronchial cells of cystic fibrosis patients and lung cell migration: Biochemical properties and a plausible mode of action 155
Antibacterial and anti-inflammatory activity of an antimicrobial peptide synthesized with D amino acids 155
Large-scale screening of organ specific autoantibodies in patients with autoimmune thyroid diseases 153
Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. 150
Antibacterial peptides and analogues thereof 149
Bioactive peptides from libraries 147
Branched peptides as targeting agents for tumor imaging and therapy 146
Antimicrobial peptide, branched forms thereof, and their use in the treatment of bacterial infections 146
Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting 145
Branched multimeric peptides for tumor diagnosis and therapy 142
Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity 140
Mimicking the nicotinic receptor binding site by a single chain Fv selected by competitive panning from a synthetic phage library 138
The development of antimicrobial peptides as new antibacterial drugs 137
Branched neurotensin for tumor targeting 136
Design and in vitro evaluation of branched peptide conjugates:turning nonspecific cytotoxic drugs into tumor-selective agents 135
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 132
Biochemical filtering of a protein-protein docking simulation identifies the structure of a complex between a recombinant antibody fragment and alpha-bungarotoxin 131
A branched peptide mimotope of the nicotinic receptor binding site is a potent synthetic antidote against the snake neurotoxin alpha-bungarotoxin 131
Molecular basis of branched peptides resistance to enzyme proteolysis 130
COMPOSTI ANTI TNF-ALPHA E LORO USI 127
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 127
Neurotensin-derived branched peptides and uses thereof 125
Mimotopes of the nicotinic receptor binding site selected by a combinatorial peptide library 124
Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles 124
Branched Neurotensin peptides for tumor personalized therapy 123
ANTICORPI E PEPTIDI -I farmaci del XXI secolo- 122
BRANCHED PEPTIDES AS THERAPEUTICS 122
Synthetic antidotes against snake neurotoxins 122
Tumor imaging with tetrabranched neurotensin 122
Dendrimeric peptide inhibitors of anthrax lethal and edema factor 121
Endocytosis and trafficking of heparan sulfate proteoglycans in triple-negative breast cancer cells unraveled with a polycationic peptide 120
The antimicrobial peptide M33. An example of drug development 119
Dendrimeric peptide inhibitors of anthrax lethal and edema factors 119
The antimicrobial peptide M33. An example of drug development 115
Tumor selective targeting by branched peptides 115
Phage display and colony filter screening for high-throughput selection of antibody libraries 114
Biochemical characterization and strong in vivo activity of a novel antimicrobial peptide specific for gram-negative bacteria 114
TARGETING BY AFFINITY MATURED RECOMBINANT ANTIBODY FRAGMENTS OF AN ANGIOGENESIS ASSOCIATED FIBRONECTIN ISOFORM 111
Turning nonspecific cytotoxic drugs into tumor-selective agents via conjugation to branched peptides. 110
Strategies for the construction and use of peptide and antibody libraries displayed on phages. 110
Multiple Antigen Peptides (MAP) as antidotes against snake neurotoxin intoxication 107
Solubility improvement of an anthrax toxin peptide inhibitor by rational aminoacid randomization 107
Esculentin(1-21), an amphibian skin membrane-active peptide with potent activity on both planktonic and biofilm cells of the bacterial pathogen Pseudomonas aeruginosa. 107
Target Selective Drug Delivery through Liposome Labeled with Oligobranched Neurotensin Peptides 106
null 105
Peptide sequences, their branched form and use thereof for antimicrobial applications 103
NMR study of the secondary structure and biopharmaceutical formulation of an active branched antimicrobial peptide 102
Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo 100
Phage display of antibody fragments 100
Rational design and molecular diversity for the construction of anti-alpha-bungarotoxin antidotes with high affinity and in vivo efficiency 100
Branched neurotensin peptides for tumor targeting 96
Antimicrobial peptides active in in vitro models of endodontic bacterial infections modulate inflammation in human cardiac fibroblasts 94
Synthetic peptides in the form of dendrimers can become resistant to protease activity 93
Characterization of the branched antimicrobial peptide M6 by analyzing its mechanism of action and in vivo toxicity. 93
In vitro inhalation cytotoxicity testing of therapeutic nanosystems for pulmonary infection 90
Oligo-branched peptides for tumor targeting: From magic bullets to magic forks 89
Synthetic inhibitors of anthrax lethal toxin 87
Screening of organ-specific autoantibodies in a large cohort of patients with autoimmune thyroid diseases. 80
null 78
Dendrimeric peptides for tumor targeting 76
STRONG SYNTHETIC INHIBITORS OF ANTHRAX LETHAL TOXIN 69
Peptide Drugs 66
Peptides mimotopes of the nicotinic receptor binding site 65
In Vivo Efficacy and Toxicity of an Antimicrobial Peptide in a Model of Endotoxin-Induced Pulmonary Inflammation 56
Safety evaluations of a synthetic antimicrobial peptide administered intravenously in rats and dogs 55
Rationally designed affinity maturation of a synthetic antidote against alpha-bungarotoxin 52
Turning Traditional Cytotoxic Drugs Into Tumour-selective Agents 48
The tardigrade damage suppressor protein modulates transcription factor and DNA repair genes in human cells treated with hydroxyl radicals and UV-C 40
Pulmonary Safety Profile of Esc Peptides and Esc-Peptide-Loaded Poly(lactide-co-glycolide) Nanoparticles: A Promising Therapeutic Approach for Local Treatment of Lung Infectious Diseases 38
Totale 13.566
Categoria #
all - tutte 43.610
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.610


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.555 0 0 0 0 182 192 208 281 208 239 90 155
2020/20212.338 106 183 48 190 75 330 226 307 205 310 152 206
2021/20221.476 87 157 96 157 93 62 60 78 58 165 171 292
2022/20232.050 114 207 253 279 221 384 50 161 170 85 87 39
2023/20241.572 51 49 130 77 69 440 550 34 8 35 20 109
2024/2025849 72 140 358 185 94 0 0 0 0 0 0 0
Totale 13.732